메뉴 건너뛰기
Journal of Rheumatology
Volumn 30, Issue 4, 2003, Pages 829-831
An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis
Author keywords

Dosing; Efficacy; Juvenile rheumatoid arthritis; Nabumetone; Pediatric; Safety
Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROBENECID; PROCAINAMIDE; SULFONAMIDE; TRIMETHOPRIM; WARFARIN;
EID: 0037384837     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (13)
References (9)
  • 1
    • 0016798647 scopus 로고
    • Pathogenic implications of age of onset in juvenile rheumatoid arthritis
    • Sullivan DB, Cassidy JT, Petty RE. Pathogenic implications of age of onset in juvenile rheumatoid arthritis. Arthritis Rheum 1975;18:251-5.
    • (1975) Arthritis Rheum , vol.18 , pp. 251-255
    • Sullivan, D.B.1    Cassidy, J.T.2    Petty, R.E.3
  • 2
    • 0026448272 scopus 로고
    • Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis
    • Fleischmann RM. Clinical efficacy and safety of nabumetone in rheumatoid arthritis and osteoarthritis. J Rheumatol 1992;19 Suppl 36:32-40.
    • (1992) J Rheumatol , vol.19 , Issue.SUPPL. 36 , pp. 32-40
    • Fleischmann, R.M.1
  • 3
    • 4243546234 scopus 로고    scopus 로고
    • Use of nabumetone to treat juvenile rheumatoid arthritis in children intolerant to other nonsteroidal anti-inflammatory drugs
    • Ostrov BE. Use of nabumetone to treat juvenile rheumatoid arthritis in children intolerant to other nonsteroidal anti-inflammatory drugs [abstract]. Arthritis Rheum 1996;39 Suppl:S58.
    • (1996) Arthritis Rheum , vol.39 , Issue.SUPPL.
    • Ostrov, B.E.1
  • 4
    • 0033404316 scopus 로고    scopus 로고
    • Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events
    • Freston JW. Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events. Am J Med 1999;107 Suppl 6A:78S-89S.
    • (1999) Am J Med , vol.107 , Issue.SUPPL. 6A
    • Freston, J.W.1
  • 5
    • 0026487129 scopus 로고
    • The unique pharmacologic profile of nabumetone
    • Blower PR. The unique pharmacologic profile of nabumetone. J Rheumatol 1992;19 Suppl 36:13-9.
    • (1992) J Rheumatol , vol.19 , Issue.SUPPL. 36 , pp. 13-19
    • Blower, P.R.1
  • 6
    • 17344384755 scopus 로고    scopus 로고
    • Current proposed revisions of the JRA criteria
    • JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Current proposed revisions of the JRA criteria. Arthritis Rheum 1997;20 Suppl:195-9.
    • (1997) Arthritis Rheum , vol.20 , Issue.SUPPL. , pp. 195-199
  • 7
    • 0022921771 scopus 로고
    • A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis
    • Cassidy JT, Levinson JE, Bass JC, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986;29:274-81.
    • (1986) Arthritis Rheum , vol.29 , pp. 274-281
    • Cassidy, J.T.1    Levinson, J.E.2    Bass, J.C.3
  • 8
    • 0028131530 scopus 로고
    • Measurement of health status in children with juvenile rheumatoid arthritis
    • Gurkirpal S, Athreya B, Fries J, Goldsmith D. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-8.
    • (1994) Arthritis Rheum , vol.37 , pp. 1761-1768
    • Gurkirpal, S.1    Athreya, B.2    Fries, J.3    Goldsmith, D.4
  • 9
    • 0034673697 scopus 로고    scopus 로고
    • Etanercept in children with polyarticular juvenile rheumatoid arthritis
    • Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000;342:763-9.
    • (2000) N Engl J Med , vol.342 , pp. 763-769
    • Lovell, D.J.1    Giannini, E.H.2    Reiff, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.